Johanne Weberpals - Department of Obstetrics and Gynecology, University of Ottawa

基本信息

浏览量：71

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 128 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Figure S6 from Vulvar Squamous Cell Carcinoma (VSCC) as Two Diseases: HPV Status Identifies Distinct Mutational Profiles Including Oncogenic Fibroblast Growth Factor Receptor 3

Johanne I. Weberpals,Bryan Lo,Marc M. Duciaume,Johanna N. Spaans,Aisling A. Clancy,Jim Dimitroulakos,Glenwood D. Goss,Harman S. Sekhon

crossref（2023）

引用0浏览0引用

Should We Abandon Hormonal Therapy in Endometrial Cancer? Outcomes of Recurrent and Metastatic Endometrial Cancer Treated with Systemic Progestins

A. Kulkarni, N. M. Andrews Wright, A. N. Forget,T. Ramsay,R. Mallick,J. I. Weberpals

CANCER MEDICINEno. 15 (2023): 16173-16180

引用0浏览0WOS引用

Figure S3 from Vulvar Squamous Cell Carcinoma (VSCC) As Two Diseases: HPV Status Identifies Distinct Mutational Profiles Including Oncogenic Fibroblast Growth Factor Receptor 3

Johanne I. Weberpals,Bryan Lo,Marc M. Duciaume,Johanna N. Spaans,Aisling A. Clancy,Jim Dimitroulakos,Glenwood D. Goss,Harman S. Sekhon

openalex（2023）

引用0浏览0引用

Supplemental Table 3 from Monensin Inhibits Epidermal Growth Factor Receptor Trafficking and Activation: Synergistic Cytotoxicity in Combination with EGFR Inhibitors

Khalil Dayekh,Stephanie Johnson‐Obaseki, Martin Corsten, Paul J. Villeneuve,Harmanjatinder S. Sekhon,Johanne I. Weberpals,Jim Dimitroulakos

openalex（2023）

引用0浏览0引用

Data from A Biomarker-enriched, Randomized Phase II Trial of Adavosertib (AZD1775) Plus Paclitaxel and Carboplatin for Women with Platinum-sensitive ≪i>tp53</i>-Mutant Ovarian Cancer

Amit M. Oza,Maria Del Pilar Estevez-Diz,Eva‐Maria Grischke,Marcia Hall,Frederik Marmé,Diane Provencher,Denise Uyar,Johanne I. Weberpals,Robert M. Wenham,Naomi Laing,Michaël Tracy,Tomoko Freshwater, Mark A. Lee,Ji Liu,Jingjun Qiu,Shelonitda Rose,Eric H. Rubin,Kathleen Moore

openalex（2023）

引用0浏览0引用

Supplementary Material and Tables from A Biomarker-enriched, Randomized Phase II Trial of Adavosertib (AZD1775) Plus Paclitaxel and Carboplatin for Women with Platinum-sensitive ≪i>tp53</i>-Mutant Ovarian Cancer

openalex

引用0浏览0引用

Table S1 from Vulvar Squamous Cell Carcinoma (VSCC) As Two Diseases: HPV Status Identifies Distinct Mutational Profiles Including Oncogenic Fibroblast Growth Factor Receptor 3

Johanne I. Weberpals,Bryan Lo,Marc M. Duciaume,Johanna N. Spaans,Aisling A. Clancy,Jim Dimitroulakos,Glenwood D. Goss,Harman S. Sekhon

crossref（2023）

引用0浏览0引用

Supplemental Table 1 from Monensin Inhibits Epidermal Growth Factor Receptor Trafficking and Activation: Synergistic Cytotoxicity in Combination with EGFR Inhibitors

Khalil Dayekh,Stephanie Johnson‐Obaseki, Martin Corsten, Paul J. Villeneuve,Harmanjatinder S. Sekhon,Johanne I. Weberpals,Jim Dimitroulakos

openalex

引用0浏览0引用

Supplementary Figure 2 from A Biomarker-enriched, Randomized Phase II Trial of Adavosertib (AZD1775) Plus Paclitaxel and Carboplatin for Women with Platinum-sensitive ≪i>tp53</i>-Mutant Ovarian Cancer

Amit M. Oza,Maria Del Pilar Estevez-Diz, Eva‐Maria Grischke, Marcia Hall, Frederik Marmé, Diane Provencher,Denise Uyar,Johanne I. Weberpals, Robert M. Wenham,Naomi Laing,Michaël Tracy,Tomoko Freshwater, Mark A. Lee, Ji Liu,Jingjun Qiu,Shelonitda Rose, Eric H. Rubin, Kathleen Moore

openalex（2023）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn